Follow
Joachim Høg Mortensen
Joachim Høg Mortensen
Head of Gastrointestinal Diseases, Nordic Bioscience
Verified email at nordicbio.com - Homepage
Title
Cited by
Cited by
Year
The good and the bad collagens of fibrosis–their role in signaling and organ function
MA Karsdal, SH Nielsen, DJ Leeming, LL Langholm, MJ Nielsen, ...
Advanced drug delivery reviews 121, 43-56, 2017
4002017
The collagen turnover profile is altered in patients with inguinal and incisional hernia
NA Henriksen, JH Mortensen, LT Sorensen, AC Bay-Jensen, MS Ågren, ...
Surgery 157 (2), 312-321, 2015
822015
Fragments of citrullinated and MMP-degraded vimentin and MMP-degraded type III collagen are novel serological biomarkers to differentiate Crohn’s disease from ulcerative colitis
JH Mortensen, LE Godskesen, MD Jensen, WT Van Haaften, LG Klinge, ...
Journal of Crohn's and Colitis 9 (10), 863-872, 2015
802015
The intestinal tissue homeostasis–the role of extracellular matrix remodeling in inflammatory bowel disease
JH Mortensen, M Lindholm, LL Langholm, J Kjeldsen, AC Bay-Jensen, ...
Expert Review of Gastroenterology & Hepatology 13 (10), 977-993, 2019
582019
Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease
WT Van Haaften, JH Mortensen, MA Karsdal, AC Bay‐Jensen, G Dijkstra, ...
Alimentary Pharmacology & Therapeutics 46 (1), 26-39, 2017
562017
Targeted antiepidermal growth factor receptor (cetuximab) immunoliposomes enhance cellular uptake in vitro and exhibit increased accumulation in an intracranial model of …
JH Mortensen, M Jeppesen, L Pilgaard, R Agger, M Duroux, V Zachar, ...
Journal of drug delivery 2013, 2013
562013
Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease
JH Mortensen, T Manon-Jensen, MD Jensen, P Hägglund, LG Klinge, ...
Plos one 12 (10), e0185855, 2017
502017
C ripto‐1 Expression in Glioblastoma Multiforme
L Pilgaard, JH Mortensen, M Henriksen, P Olesen, P Sørensen, ...
Brain Pathology 24 (4), 360-370, 2014
382014
Extracellular matrix fragments of the basement membrane and the interstitial matrix are serological markers of intestinal tissue remodeling and disease activity in dextran …
M Lindholm, T Manon-Jensen, GI Madsen, A Krag, MA Karsdal, ...
Digestive Diseases and Sciences 64, 3134-3142, 2019
282019
Enzymatic cross-linking of collagens in organ fibrosis–resolution and assessment
M Pehrsson, JH Mortensen, T Manon-Jensen, AC Bay-Jensen, ...
Expert Review of Molecular Diagnostics 21 (10), 1049-1064, 2021
262021
A specific calprotectin neo-epitope [CPa9-HNE] in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity
JH Mortensen, D Sinkeviciute, T Manon-Jensen, V Domislović, K McCall, ...
Journal of Crohn's and Colitis 16 (9), 1447-1460, 2022
232022
Abdominal wall hernias—A local manifestation of systemically impaired quality of the extracellular matrix
NA Henriksen, JH Mortensen, L Lorentzen, MS Ågren, AC Bay-Jensen, ...
Surgery 160 (1), 220-227, 2016
232016
Serological biomarkers of tissue turnover identify responders to anti-TNF therapy in Crohn's disease: a pilot study
WT van Haaften, JH Mortensen, AK Dige, H Grønbæk, CL Hvas, ...
Clinical and translational gastroenterology 11 (9), e00217, 2020
222020
A fragment of collagen type VI alpha-3 chain is elevated in serum from patients with gastrointestinal disorders
S Holm Nielsen, JH Mortensen, N Willumsen, DGK Rasmussen, ...
Scientific Reports 10 (1), 5910, 2020
212020
Serum type XVI collagen is associated with colorectal cancer and ulcerative colitis indicating a pathological role in gastrointestinal disorders
C Jensen, SH Nielsen, JH Mortensen, J Kjeldsen, LG Klinge, A Krag, ...
Cancer medicine 7 (9), 4619-4626, 2018
182018
Brain delivery systems via mechanism independent of receptor-mediated endocytosis and adsorptive-mediated endocytosis
L Bohn Thomsen, J Lichota, T Navndrup Eskehave, T Linemann, ...
Current Pharmaceutical Biotechnology 13 (12), 2349-2354, 2012
182012
Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
NI Nissen, S Kehlet, MK Boisen, M Liljefors, C Jensen, AZ Johansen, ...
Scientific Reports 11 (1), 865, 2021
172021
Serological assessment of the quality of wound healing processes in Crohn's disease
S Sun, MA Karsdal, JH Mortensen, Y Luo, J Kjeldsen, A Krag, MD Jensen, ...
Journal of gastrointestinal and liver diseases: JGLD 28 (2), 175-182, 2019
172019
The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFRα-mAb treatment in rheumatoid arthritis patients
JH Mortensen, X Guo, M De Los Reyes, MH Dziegiel, MA Karsdal, ...
Clin Exp Rheumatol 37 (1), 73-80, 2019
172019
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
AR Bourgonje, MS Alexdottir, AT Otten, R Loveikyte, AC Bay‐Jensen, ...
Alimentary Pharmacology & Therapeutics 56 (4), 675-693, 2022
142022
The system can't perform the operation now. Try again later.
Articles 1–20